Loading chat...
NV AB284
Bill
Status
6/9/2025
Primary Sponsor
Tracy Brown-May
Click for details
AI Summary
-
Requires the Director of Health and Human Services to submit a request to the federal government by October 1, 2025, to establish Medicaid reimbursement rates of at least 82% of acquisition cost for vagus nerve stimulation therapy devices prescribed for epilepsy treatment
-
Device and replacement part reimbursement rates must be separate from and in addition to reimbursement for medical care related to implantation, repair, or part replacement
-
Appropriates $54,728 for FY 2025-2026 and $240,004 for FY 2026-2027 from the State General Fund to the Division of Health Care Financing and Policy for implementation and computer system upgrades
-
Authorizes additional non-General Fund expenditures of $188,270 for FY 2025-2026 and $700,098 for FY 2026-2027 for the same purposes
-
Appropriation provisions take effect July 1, 2025; reimbursement rate requirements take effect March 1, 2026
Legislative Description
Requires the Director of the Department of Health and Human Services to seek to establish certain rates of reimbursement under Medicaid for certain devices to treat epilepsy. (BDR S-571)
Last Action
Chapter 417.
6/9/2025